Zentalis Pharmaceuticals Current Cash

Zentalis Pharmaceuticals (ZNTL) currently reports a current cash of $25M as of June 2026. That compares with $38M in the prior-year period — down 34.1% year over year. Use the charts on this page to explore Zentalis Pharmaceuticals's current cash history and peer comparisons.

Zentalis Pharmaceuticals's current cash decreased from $38M to $25M — a 34.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zentalis Pharmaceuticals reported $25M in current cash as of June 2026. That compares with $38M in the prior-year period — down 34.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zentalis Pharmaceuticals, and consider following ZNTL for alerts when major investors trade the stock.

Zentalis Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $25M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZNTL with unrelated industries.